Skip to content
An Initiative of AVAC
Search

Resource Library

The PrEPWatch Resource Database offers a wide range of material on the status of PrEP as an option for biomedical HIV prevention around the world. Search this database to find step-by-step guidance for rolling out PrEP, summaries of the research to date on safety, efficacy and implementation, tools to assist planning and roll out, country updates on PrEP policy and access, and lessons learned from those efforts.

Filter By
Multiple filters can be used at once

Showing results 61 - 70 of 112

Selected Filters:
7 July 2022

#GarawaPrEPa Campaign from Chitungwiza, Zimbabwe

Pangaea Zimbabwe AIDS Trust (PZAT), an implementing partner in the USAID- and PEPFAR-funded OPTIONS Consortium, used the PrEP Communications Accelerator to develop a PrEP demand creation campaign targeting AGYW in Chitungwiza, Zimbabwe. To learn more about this campaign, see this campaign photo story. Print Materials Flyer Poster (friends) Poster (family) Poster (peace) Poster (shades) Poster…

Community/Advocacy, Demand Creation/Marketing

Document
7 July 2022

Chagua PrEP, Chagua Life Campaign from Kiambu County, Kenya

Chagua Life is a campaign led by LVCT Health, an implementing partner the OPTIONS Consortium. Chagua Life is a PrEP campaign for adolescent girls and young women (AGYW) in Kiambu County, Kenya.

Community/Advocacy, Demand Creation/Marketing

7 July 2022

An Advocates’ Primer on Long-Acting Injectable Cabotegravir for PrEP

Results from two large-scale efficacy trials found that injectable cabotegravir (CAB-LA), given every two months, was effective as a form of pre-exposure prophylaxis (PrEP) in preventing HIV in gay men and other men who have sex with men, transgender women who have sex with men, and cisgender women. CAB-LA was developed by ViiV Healthcare and…

Community/Advocacy

External Link
7 July 2022

BioPIC Adaptable Product Introduction Framework

This framework is intended to inform stakeholders involved in all stages of product introduction from clinical research to rollout in low- and middle-income countries (LMICs). While the framework focuses on activities to begin in parallel to phase III clinical trials, stakeholders in early product development phases may also want to understand what to expect in…

Community/Advocacy, Demand Creation/Marketing, Financing & Costing, Monitoring & Evaluation, Research, Service Delivery, Supply Chain Management

Document
7 July 2022

A Collaborative Approach to HIV Prevention Product Introduction

The HIV prevention product pipeline offers exciting potential to curb HIV incidence. But we know from previous products that translating trial efficacy to population impact is challenging without coordinated effort.

Community/Advocacy

External Link
7 July 2022

Interactive Oral PrEP Implementation Timelines: Kenya

This presentation provides an overview of the journey of rolling out oral PrEP in Kenya.

Community/Advocacy

External Link
7 July 2022

Interactive Oral PrEP Implementation Timelines: South Africa

This presentation provides an overview of the journey of rolling out oral PrEP in South Africa.

Community/Advocacy

External Link
7 July 2022

Oral PrEP Re-initiation Standard Operating Procedures

Oral pre-exposure prophylaxis (PrEP) clients may choose to stop and restart oral PrEP due to factors such as changes in perceived personal exposure to HIV, the behaviors of a sexual or injecting drug partner, the burden of taking a daily pill, side effects, and mobility. Oral PrEP programs should counsel patients on how to safely…

Community/Advocacy, Demand Creation/Marketing

Document
7 July 2022

Healthcare Worker Guide to Providing PrEP

Calling all healthcare providers! This video is for you, as we outline some top tips and guidance on prescribing PrEP. We want to empower you with the information you need about PrEP, inform you on how best to counsel your client on what’s right for them, and support them in a non-judgmental manner. This is…

Community/Advocacy, Demand Creation/Marketing

External Link
7 July 2022

The Years Ahead in Biomedical HIV Prevention Research

This graphic shows the updated status of large-scale prevention trials through 2024.

Community/Advocacy

External Link